Medo.ai
About Medo.ai
Medo.ai was a healthcare AI company specializing in developing medical imaging technology that integrated artificial intelligence with ultrasound devices. Its primary aim was to democratize medical imaging by enabling even novice users to accurately detect common and critical conditions. The company’s technology leveraged AI and cloud computing to streamline the process of ultrasound scanning and analysis, effectively reducing or eliminating the need for an expert to perform or interpret the scans.
For physicians, Medo.ai’s solutions offered a significant advancement in point-of-care diagnostics. The AI algorithms automated both image acquisition and interpretation, assisting healthcare professionals without specialized ultrasound training in conducting accurate examinations and diagnosing conditions. This capability was particularly demonstrated in areas such as the diagnosis of developmental dysplasia of the hip (DDH) in infants and the assessment of thyroid conditions, with some algorithms receiving FDA clearance.
The integration of Medo.ai’s technology into clinical workflows aimed to lower the barrier to entry for using advanced digital imaging, improve diagnostic efficiencies, and facilitate earlier detection and treatment. The vision was to transform portable ultrasound devices into a “21st-century stethoscope,” making internal body imaging as accessible and straightforward as using a smartphone camera.
Focus Areas
Business Intelligence
| Key Investors | Edmonton Unlimited, Elev8.vc, Entrepreneurs First, Qualgro, SGInnovate |
| Partnerships | Medical Imaging Consultants (MIC), Kailo Medical |
| Acquisitions | Exo (acquired on July 26, 2022) |
| Technology | AI and cloud computing, AI-augmented 3D ultrasound, proprietary Sweep AI technology |
| FDA Clearances | 2 cleared products (estimated) |
What Physicians Need to Know
Medo.ai's technology offers significant advantages for physicians by reducing the expertise required to perform and interpret ultrasound scans, allowing non-experts to conduct high-quality exams quickly and accurately. This leads to faster diagnoses and treatment, especially for conditions like hip dysplasia and thyroid nodules, and can significantly improve workflow efficiency by automating tedious tasks like measurements and reporting. The point-of-care capabilities extend expert-level diagnostics to various clinical settings, potentially reducing patient travel and wait times, and contributing to earlier disease detection. By streamlining documentation and interpretation, Medo.ai helps reduce administrative burden and physician burnout, allowing more focused time on patient care.
Medo.ai's proprietary Sweep AIu2122 technology is being integrated into Exo's ultrasound platform, enhancing their handheld ultrasound devices and workflow solutions. This integration aims to make ultrasound imaging more accessible and easier to use for a wider range of caregivers. The cloud-based nature of Medo.ai's platform suggests potential for seamless integration with existing healthcare IT systems, including electronic medical records (EMRs), to streamline documentation and data management, though specific EMR integrations are not detailed in all public information.
Reviews & Opinions
Videos
News, demos, and interviews about Medo.ai.
Videos load interactively. If none appear, search YouTube for Medo.ai →
Press & Coverage
Frequently Asked Questions
Investors
Who's funded Medo.ai.
Related Companies
Visiopharm is a leading provider of AI-driven precision pathology software, catering to both research and diagnostic applications. For physicians, Visiopharm offers advanced tools that transform pathology through image analysis, aiming to enhance precision and productivity in pathology labs. The company has developed nine diagnostic algorithms cleared under IVDR for EU and UK customers, which provide […]
TSI (Transworld Systems Inc.) is a long-standing company primarily known for its debt collection and business process outsourcing services. While they serve various industries, including healthcare, their core offering is focused on accounts receivable management and collections rather than healthcare-specific AI development. They provide solutions to help healthcare providers manage patient accounts, improve cash flow, […]
TrialX is a healthcare AI company specializing in clinical research and space health informatics. The company develops platforms designed to connect patients with clinical trials and facilitate research data collection. Their offerings include an enterprise patient recruitment platform (iConnect) that provides a clinical trials finder (Dory), study website builders, pre-screeners, referral tracking, and volunteer registries. […]
Thinkitive is a global IT services and solutions company that specializes in digital transformation, enterprise application services, outsourced product development, and a testing center of excellence. For physicians, Thinkitive offers a range of AI-driven healthcare solutions designed to streamline clinical and administrative workflows, enhance patient care, and improve operational efficiency. Their services include custom healthcare […]
Taction Software is a U.S.-based healthcare IT and custom software development company specializing in HIPAA-compliant solutions. They build AI-powered applications for healthcare, ranging from rapid clinical AI prototypes to production-grade systems with EHR integration, ambient documentation, and predictive analytics. The company focuses on transforming healthcare delivery through secure, compliant, and innovative software solutions that aim […]
SUPERWISE offers an enterprise AI governance and operations platform designed to help organizations, including those in healthcare, deploy and manage autonomous AI systems with oversight and control. The platform addresses governance, compliance, and operational challenges associated with AI and machine learning deployments. It features real-time guardrails for AI systems, model observability capabilities, and compliance automation, […]